Besides, it is no efficient in controlling parameters other than hemodynamic system (HbA1c, endothelin 1 serum level, high sensitivity C-reactive protein plasma level and interleukin six serum level) in type II diabetes patients (Santi et al., 2015; Poolsup et al., 2016). The gene discussed is EDN1; the disease is type 2 diabetes mellitus.